Biora Therapeutics Overview
Biora Therapeutics (BIOR) has a ROE of 29.58%, above the Healthcare sector average of 21.3%.
Get informed when a big investor buys or sells
+ Follow29.58%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, BIOR shows a ROE of 29.58%. That is above the Healthcare sector average of 21.3%. Scroll down for historical charts and peer comparison views.
The Healthcare sector average ROE is about 21.3%. Biora Therapeutics is at 29.58%, which is higher that average. That is roughly 38.8% above the sector mean. Use the comparison chart on this page to see how BIOR stacks up against individual peers as well.
Check the historical chart to see whether BIOR's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Biora Therapeutics with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has Biora Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 29.58%) with ownership activity and broader fundamentals.
The Healthcare average ROE is about 21.3%, while BIOR is at 29.58%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
